
Reconstructive Surgery India
About Reconstructive Surgery India
Data last updated:
Reconstructive Surgery India was a private not for profit company based in Hyderabad, Telangana, India, operated as a subsidiary of Resurge International. The company has been dissolved under section 59(8) as per MCA records and no longer exists as a legal entity. Any dealings with a dissolved entity carry legal and financial risk. It operated in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 29 March 2012.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2012NPL080017.
The company had an authorised share capital of ₹1 Lakh. It was led by directors including Shailesh Baheti (Irp/Rp/Liquidator) and Geeta Vora.
Its last annual general meeting (AGM) was held on 07 July 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Plt Nos.188 189 Rr Towers West Block 5th Floor Kavuri Hills Phase – I Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.7 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.02 Lakh (net margin -21.8%) and EBITDA of -₹1.02 Lakh (EBITDA margin -21.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 99% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlt Nos.188 189 Rr Towers West Block 5th Floor Kavuri Hills Phase – I Madhapur, Hyderabad, Telangana, India – 500081
- IndustryHealthcare, Other Hospital and Medical Care Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Reconstructive Surgery India
Reconstructive Surgery India has one previous CIN (Corporate Identification Number): U85100AP2012NPL080017. The current CIN is U85100TG2012NPL080017, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100TG2012NPL080017 | Current |
| U85100AP2012NPL080017 | Previous |
Business Activity of Reconstructive Surgery India
The main business activity of Reconstructive Surgery India is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Reconstructive Surgery India
Reconstructive Surgery India is audited by SHARAD SINHA for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHARAD SINHA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Reconstructive Surgery India
Reconstructive Surgery India has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailesh Baheti Also directs: Truserve Strategies Private Limited | Irp/Rp/Liquidator | 21 Oct 2023 | 2 Years 11 Months | As last reported |
| Geeta Vora | Director | 14 Aug 2014 | 12 Years 1 Months | As last reported |
| Sujata Mehta | Director | 07 May 2015 | 11 Years 4 Months | As last reported |
| Deeksha Gehlot | Director | 15 Dec 2018 | 7 Years 9 Months | As last reported |
Financials of Reconstructive Surgery India FY 2023 filings available
Reconstructive Surgery India reported revenue of ₹4.7 Lakh (up 153% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Reconstructive Surgery India
Revenue has grown at a compounded annual rate (CAGR) of 99% over five years, including 153% growth in the latest year. EBITDA rose 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Reconstructive Surgery India
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.02 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.02 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Reconstructive Surgery India
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -21.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -21.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Reconstructive Surgery India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Reconstructive Surgery India
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Reconstructive Surgery India
Reconstructive Surgery India does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Reconstructive Surgery India
Employment history and EPFO contributions of people linked to Reconstructive Surgery India.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Reconstructive Surgery India
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Reconstructive Surgery India
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Reconstructive Surgery India
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Reconstructive Surgery India
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Reconstructive Surgery India
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Reconstructive Surgery India
Frequently Asked Questions about Reconstructive Surgery India
Reconstructive Surgery India has been "Dissolved Under Section 59(8)" as per MCA records. The company has ceased to exist as a legal entity. Any contracts or dealings with a dissolved entity may be legally unenforceable.
Reconstructive Surgery India was a private not for profit company based in Hyderabad, Telangana, India. The company worked in other hospital and medical care activities, within the healthcare industry. It was incorporated on 29 March 2012 and is registered under CIN U85100TG2012NPL080017. The company is recorded as dissolved under section 59(8) in MCA records and no longer exists as a legal entity.
Reconstructive Surgery India was incorporated on 29 March 2012. It is registered with the Registrar of Companies, Hyderabad.
Reconstructive Surgery India had 4 directors:
- Geeta Vora - Director
- Sujata Mehta - Director
- Deeksha Gehlot - Director
- Shailesh Baheti - Irp/Rp/Liquidator
The CIN (Corporate Identification Number) of Reconstructive Surgery India is U85100TG2012NPL080017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Reconstructive Surgery India is at Plt Nos.188 189 Rr Towers West Block 5th Floor Kavuri Hills Phase – I Madhapur, Hyderabad, Telangana, India – 500081.
Reconstructive Surgery India reported revenue of ₹4.7 Lakh for FY 2023 (up 153% YoY).
The authorised capital is ₹1 Lakh.
Reconstructive Surgery India reported a net loss of ₹1.02 Lakh (net margin -21.8%) and EBITDA of -₹1.02 Lakh (EBITDA margin -21.8%) for FY 2023, as per its filed financial statements.